Search Results - "Lewin, Sharon R."
-
1
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Published in The Lancet (British edition) (19-07-2014)“…Summary HIV prevalence is increasing worldwide because people on antiretroviral therapy are living longer, although new infections decreased from 3·3 million…”
Get full text
Journal Article -
2
The end of AIDS: HIV infection as a chronic disease
Published in The Lancet (British edition) (02-11-2013)“…Summary The success of antiretroviral therapy has led some people to now ask whether the end of AIDS is possible. For patients who are motivated to take…”
Get full text
Journal Article -
3
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
Published in Nature medicine (01-04-2020)Get full text
Journal Article -
4
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
Published in PLoS pathogens (01-07-2016)“…HIV persists in a small pool of latently infected cells despite antiretroviral therapy (ART). Identifying cellular markers expressed at the surface of these…”
Get full text
Journal Article -
5
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission
Published in The Lancet (British edition) (28-07-2018)“…Recent trends in the HIV response are especially concerning. Although the number of new HIV infections and AIDS-related deaths have markedly decreased since…”
Get full text
Journal Article -
6
PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals
Published in Nature communications (18-02-2019)“…HIV persists in latently infected CD4 + T cells during antiretroviral therapy (ART). Immune checkpoint molecules, including PD-1, are preferentially expressed…”
Get full text
Journal Article -
7
HIV cure and eradication: how will we get from the laboratory to effective clinical trials?
Published in AIDS (London) (24-04-2011)“…Combination antiretroviral therapy (cART) has led to a major reduction in HIV-related mortality and morbidity; however, HIV can still not be cured. Achieving…”
Get full text
Journal Article -
8
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
Published in The Journal of infectious diseases (15-03-2011)“…Background. Chronic human immunodeficiency virus (HIV) infection is associated with intestinal permeability and microbial translocation that contributes to…”
Get full text
Journal Article -
9
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Published in The lancet HIV (01-10-2014)“…Summary Background Activating the expression of latent virus is an approach that might form part of an HIV cure. We assessed the ability of the histone…”
Get full text
Journal Article -
10
An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients
Published in PLoS pathogens (01-12-2013)“…The possibility of HIV-1 eradication has been limited by the existence of latently infected cellular reservoirs. Studies to examine control of HIV latency and…”
Get full text
Journal Article -
11
Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance
Published in Nature communications (13-07-2021)“…The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously…”
Get full text
Journal Article -
12
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
Published in The lancet HIV (01-12-2015)“…Summary Background In vitro, disulfiram activated HIV transcription in a primary T-cell model of HIV latency and in a pilot clinical study increased plasma HIV…”
Get full text
Journal Article -
13
Combination Immune Checkpoint Blockade to Reverse HIV Latency
Published in The Journal of immunology (1950) (01-03-2020)“…In people living with HIV on antiretroviral therapy, HIV latency is the major barrier to a cure. HIV persists preferentially in CD4 T cells expressing multiple…”
Get full text
Journal Article -
14
Perceptions of HIV cure research among people living with HIV in Australia
Published in PloS one (24-08-2018)“…Participation in HIV cure-related clinical trials that involve antiretroviral treatment (ART) interruption may pose substantial individual risks for people…”
Get full text
Journal Article -
15
HDAC inhibitors in HIV
Published in Immunology and cell biology (01-01-2012)“…Combination antiretroviral therapy (cART) has led to a very substantial reduction in morbidity and mortality in HIV‐infected patients; however, cART alone is…”
Get full text
Journal Article -
16
Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy
Published in Nature communications (12-07-2017)“…The imminent threat of viral epidemics and pandemics dictates a need for therapeutic approaches that target viral pathology irrespective of the infecting…”
Get full text
Journal Article -
17
Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells
Published in PLoS pathogens (01-10-2015)“…Recent efforts to cure human immunodeficiency virus type-1 (HIV-1) infection have focused on developing latency reversing agents as a first step to eradicate…”
Get full text
Journal Article -
18
The significance and expectations of HIV cure research among people living with HIV in Australia
Published in PloS one (04-03-2020)“…Most people living with HIV (PLHIV) with reliable access to antiretroviral treatment (ART) have a life expectancy similar to uninfected populations. Despite…”
Get full text
Journal Article -
19
Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage
Published in Current opinion in HIV & AIDS (01-01-2015)“…PURPOSE OF REVIEWThe purpose of this review was to summarize recent studies on the effect of early antiretroviral therapy (ART) in HIV-infected patients on…”
Get full text
Journal Article -
20
Immune checkpoint blockade in HIV
Published in EBioMedicine (01-02-2022)“…Antiretroviral therapy (ART) has dramatically improved life expectancy for people with HIV (PWH) and helps to restore immune function but is not curative and…”
Get full text
Journal Article